In February, Erytech Pharma SA ERYP announced its proposed combination with Pherecydes Pharma S.A. In June, Erytech announced that Akkadian initiated proceedings to postpone the vote, scheduled on 23 ...
Fast Track designation for eryaspase underscores the urgent need for potential new treatment options for patients with second line metastatic pancreatic cancer LYON, France and CAMBRIDGE, Mass., April ...
Days after throwing down $350 million to beef up biologics manufacturing in Indiana, high-flying CDMO Catalent is buying a cell therapy plant on the East Coast. Catalent has paid $44.5 million for ...
NANTES, France--(BUSINESS WIRE)--Regulatory News: PHERECYDES Pharma (FR0011651694 – ALPHE), a biotechnology company specializing in extended phage therapy for treating antibiotic-resistant and/or ...
Erytech Pharma, which is developing treatments for rare cancers and orphan diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company is listed on ...
LYON, France, April 12, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating ...
LYON, France--(BUSINESS WIRE)--Regulatory News: Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol : ERYP) ...
LYON, France--(BUSINESS WIRE)--Oct 22, 2008 - ERYtech Pharma, a French biotechnology company, will present very promising results from its original approach on antitumor vaccination at the 6th ...
Thank you for standing by, and welcome to the conference call on the proposed merger between ERYTECH Pharma and Pherecydes Pharma. [Operator Instructions]. As a reminder, today's program is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results